Terminated × Central Nervous System Neoplasms × Sarcoma × Clear all STIR
Phase 2 Terminated
15 enrolled 11 charts
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
Phase 1/2 Terminated
7 enrolled 9 charts
Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma
Phase 2 Terminated
5 enrolled
Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors
Phase 3 Terminated
Radiation Therapy Followed by Bleomycin in Treating Adult Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
Phase 2 Terminated
19 enrolled 4 charts
MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma
Phase NA Terminated
15 enrolled 6 charts
Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols
Terminated
767 enrolled
Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma
Phase 1/2 Terminated
12 enrolled 7 charts
Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme
Phase 2 Terminated
12 enrolled 15 charts
Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme
Phase 1 Terminated
15 enrolled
Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With Glioma
Phase NA Terminated
1 enrolled 2 charts
Poly-ICLC
Phase 2 Terminated
31 enrolled 8 charts
Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy
Terminated
10 enrolled
Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme
Phase 2 Terminated
15 enrolled
MT2004-30: Tomotherapy for Solid Tumors
Phase 1 Terminated
23 enrolled
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
Phase 1 Terminated
13 enrolled
O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy
Phase 2 Terminated
12 enrolled 10 charts
Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9
Phase NA Terminated
12 enrolled 6 charts
Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma
Phase 1 Terminated
7 enrolled
Cyberknife Radiosurgery and Quality of Life
Terminated
15 enrolled
Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT
Phase 2 Terminated
35 enrolled 12 charts
Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme
Phase 1 Terminated
36 enrolled
Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme
Phase 1 Terminated
10 enrolled
VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma
Phase 1 Terminated
14 enrolled
Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors
Phase 1 Terminated
19 enrolled
Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Phase 1 Terminated
8 enrolled